医薬品開発業務受託機関の市場規模、シェア、成長分析、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界の医薬品開発業務受託機関の市場規模は、2022年に約680億米ドルとなり、2023年の751億米ドルから上昇し、予測期間（2024年～2031年）のCAGRは9.5%で、2031年までには1,552億米ドルに達すると予測されています。

世界の医薬品開発業務受託機関（CRO）市場は、臨床試験の複雑化とアウトソーシング調査サービスに対する需要の高まりにより、堅調な成長を遂げています。CROは臨床試験管理、データ管理、薬事、ラボサービスなど幅広いサービスを提供しています。CROは、製薬、バイオテクノロジー、医療機器企業が研究開発プロセスを合理化し、コストを削減し、新製品の市場投入までの時間を短縮できるよう支援しています。同市場は、大規模なフルサービスCROから小規模なニッチ企業まで多数のプレーヤーが存在し、高度に細分化されているのが特徴です。技術的進歩、特にデータ分析とデジタルヘルスソリューションは、市場力学に大きな影響を与えています。個別化医療が重視されるようになり、慢性疾患の有病率が高まっていることも、市場の拡大に寄与しています。さらに、主要市場プレーヤー間の戦略的提携やM&Aが競合情勢を形成しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要展望
• 供給需要動向分析
• セグメント別機会分析

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 市場のエコシステム
• バリューチェーン分析
• 価格分析
• ケーススタディ分析
• 技術分析
• 規制分析
• イノベーションマトリクス
• 主要な投資分析
• 主要な成功要因
• 競合の程度

医薬品開発業務受託機関市場：タイプ別

• 市場概要
• 臨床研究サービス
  • フェーズ別
  • フェーズIII
  • フェーズII
  • フェーズI
  • フェーズIV
  • 研究デザイン別（フェーズIII・フェーズIV）
  • 介入
  • リアルワールドエビデンス（RWE）
• 初期開発サービス
  • 化学、製造、制御サービス
  • 前臨床サービス
  • 薬物動態学 / 薬力学サービス
  • 毒性試験サービス
  • その他の前臨床サービス
  • 発見研究
• ラボサービス
  • 分析試験サービス
  • 物理的特性評価サービス
  • 原材料試験サービス
  • バッチリリーステストサービス
  • 安定性試験サービス
  • その他の分析試験サービス
  • バイオ分析試験サービス
• コンサルティングサービス
• データ管理サービス

医薬品開発業務受託機関市場：治療領域別

• 市場概要
• 腫瘍学
  • 乳がん
  • 肺がん
  • 大腸がん
  • 前立腺がん
  • その他のがん
• 感染症
• CVS障害
• 神経学
• ワクチン
• 代謝疾患/内分泌学
• 免疫疾患
• 精神医学
• 呼吸器疾患
• 皮膚科
• 眼科
• 消化器疾患
• 泌尿器と女性の健康
• 血液学
• その他の治療領域

医薬品開発業務受託機関市場：エンドユーザー別

• 市場概要
• 製薬・バイオ医薬品企業
• 医療機器企業
• 学術機関

医薬品開発業務受託機関市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• IQVIA
• Laboratory Corporation of America Holdings（Labcorp）
• PPD Inc.（a part of Thermo Fisher Scientific, Inc.）
• Syneos Health Inc.
• WuXi AppTec Co., Ltd.
• Charles River Laboratories International, Inc.
• Parexel International Corporation
• Pharmaron Beijing Co., Ltd.
• ICON PLC
• Medpace Holdings, Inc.
• SGS SA
• Frontage Holdings Corporation
• PSI CRO AG
• BioAgile Therapeutics Pvt. Ltd.
• Firma Clinical Research, LLC
• AccuLab Life Sciences
• Novotech Health Holdings
• KCR（formerly Kiecana Clinical Research）
• Linical Co., Ltd.
• Advanced Clinical
• Azelix LLC
• Clinical Trial Service BV
• Pepgra Healthcare Pvt. Ltd.
• Worldwide Clinical Trials Holdings Inc.
• CTI Clinical Trial and Consulting Services, Inc

Global Contract Research Organization Market size was valued at around 68 billion in 2022 and is expected to rise from USD 75.1 billion in 2023 to reach a value of USD 155.2 billion by 2031, at a CAGR of 9.5% over the forecast period (2024-2031).

The global Contract Research Organization (CRO) market has experienced robust growth due to the increasing complexity of clinical trials and the rising demand for outsourced research services. CROs provide a range of services including clinical trial management, data management, regulatory affairs, and laboratory services. They are instrumental in helping pharmaceutical, biotechnology, and medical device companies streamline their R&D processes, reduce costs, and accelerate time-to-market for new products. The market is characterized by a high degree of fragmentation, with numerous players ranging from large, full-service CROs to smaller niche firms. Technological advancements, particularly in data analytics and digital health solutions, are significantly impacting the market dynamics. The growing emphasis on personalized medicine and the increasing prevalence of chronic diseases are also contributing to the market's expansion. Additionally, strategic collaborations and mergers and acquisitions among key market players are shaping the competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contract Research Organization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contract Research Organization Market Segmental Analysis

Global Contract Research Organization Market is segmented by Type, Therapeutic Area, End User, and region. Based on Product, the market is segmented into Clinical Research Services ( Phase (Phase III, Phase II, Phase I, Phase IV), By Study Design (For Phase III & IV) (Interventional, Real World Evidence (RWE)), Early phase development Services (Chemistry, Manufacturing and Controls Services, Preclinical Services (Pharmacokinetics/ Pharmacodynamics Services, Toxicology Testing Services, Other Preclinical Services), Discovery Studies), Laboratory Services (Analytical Testing Services (Physical Characterization Services, Raw Material Testing Services, Batch Release Testing Services, Stability Testing Services, Other Analytical Testing Services), Bioanalytical Testing Services), Consulting Services, and Data Management Services. Based on Therapeutic Area, the market is segmented into Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Cancer), Infectious Diseases, CVS Disorders, Neurology, Vaccines, Metabolic Disorders/Endocrinology, Immunological Disorders, Psychiatry, Respiratory Disorders, Dermatology, Ophthalmology, Gastrointestinal Diseases, Genitourinary & Women's Health, Hematology, and Other Therapeutic Areas. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Contract Research Organization Market

One major driver of the global CRO market is the rising need for cost-effective and efficient R&D solutions. Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trials and other research activities to CROs to manage costs and mitigate risks associated with drug development. CROs offer specialized expertise and resources that can help streamline the drug development process, reduce operational costs, and improve the overall efficiency of clinical trials. This trend is particularly prevalent among smaller companies and startups that lack the extensive infrastructure required for large-scale clinical research. By leveraging CROs, these organizations can focus on their core competencies while benefiting from the CROs' experience, advanced technologies, and global reach, which ultimately supports faster and more cost-effective product development.

Restraints in the Global Contract Research Organization Market

A significant restraint in the global CRO market is the regulatory complexity and variability across different regions. CROs must navigate diverse regulatory requirements and standards set by various health authorities worldwide, which can be challenging and time-consuming. The differences in regulations, clinical trial procedures, and data privacy laws between countries can lead to delays, increased costs, and potential compliance issues. This regulatory burden can affect the efficiency of clinical trials and pose challenges for CROs in managing multi-regional studies. Additionally, discrepancies in regulatory guidelines can impact the standardization of trial protocols and data reporting, complicating the process for both CROs and their clients.

Market Trends of the Global Contract Research Organization Market

A prominent trend in the global CRO market is the growing integration of advanced technologies, such as artificial intelligence (AI) and machine learning, into clinical trials. These technologies are revolutionizing the way clinical research is conducted by enhancing data analysis, improving patient recruitment, and optimizing trial designs. AI algorithms can analyze vast amounts of data to identify potential drug candidates, predict patient responses, and uncover new insights that can accelerate the drug development process. Additionally, machine learning tools are being used to streamline data management and enhance decision-making processes. This technological advancement is helping CROs deliver more accurate and efficient research outcomes, thereby increasing their value proposition to pharmaceutical and biotechnology companies. The adoption of these technologies is expected to continue growing, further driving innovation and efficiency in the CRO market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Regulatory Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Contract Research Organization Market by Type

• Market Overview
• Clinical Research Services
  • By Phase
  • Phase III
  • Phase II
  • Phase I
  • Phase IV
  • By Study Design (For Phase III & IV)
  • Interventional
  • Real World Evidence (RWE)
• Early phase development Services
  • Chemistry, Manufacturing and Controls Services
  • Preclinical Services
  • Pharmacokinetics/ Pharmacodynamics Services
  • Toxicology Testing Services
  • Other Preclinical Services
  • Discovery Studies
• Laboratory Services
  • Analytical Testing Services
  • Physical Characterization Services
  • Raw Material Testing Services
  • Batch Release Testing Services
  • Stability Testing Services
  • Other Analytical Testing Services
  • Bioanalytical Testing Services
• Consulting Services
• Data Management Services

Contract Research Organization Market by Therapeutic Area

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Other Cancer
• Infectious Diseases
• CVS Disorders
• Neurology
• Vaccines
• Metabolic Disorders/Endocrinology
• Immunological Disorders
• Psychiatry
• Respiratory Disorders
• Dermatology
• Ophthalmology
• Gastrointestinal Diseases
• Genitourinary & Women's Health
• Hematology
• Other Therapeutic Areas

Contract Research Organization Market by End User

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Contract Research Organization Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc. (a part of Thermo Fisher Scientific, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron Beijing Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Firma Clinical Research, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccuLab Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech Health Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR (formerly Kiecana Clinical Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azelix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Trial Service BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments